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ABSTRACT

Glycans play a vital role in health, disease, bioenergy, biomaterials, and biotherapeutics. As a result, there is keen interest to identify and increase glycan data in
bioinformatics databases like ChEBI and PubChem, and connecting them to resources
at the EMBL-EBI and NCBI to facilitate access to important annotations at a global
level. GlyTouCan is a comprehensive archival database that contains glycans obtained
primarily through batch upload from glycan repositories, glycoprotein databases, and
individual laboratories. In many instances, the glycan structures deposited in
GlyTouCan may not be fully defined or have supporting experimental evidence and
citations. Databases like ChEBI and PubChem were designed to accommodate
complete atomistic structures with well-defined chemical linkages. As a result, they
cannot easily accommodate the structural ambiguity inherent in glycan databases.
Consequently, there is a need to improve the organization of glycan data coherently to
enhance connectivity across the major NCBI, EMBL-EBI, and glycoscience databases.

This paper outlines a workflow developed in collaboration between GlyGen, ChEBI, and
PubChem to improve the visibility and connectivity of glycan data across these
resources. GlyGen hosts a subset of glycans (~29,000) from the GlyTouCan database
and has submitted valuable glycan annotations to the PubChem database and
integrated over 10,500 (including ambiguously defined) glycans into the ChEBI
database. The integrated glycans were prioritized based on links to PubChem and
connectivity to glycoprotein data. The pipeline provides a blueprint for how glycan data
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can be harmonized between different resources. The current PubChem, ChEBI, and
GlyTouCan mappings can be downloaded from GlyGen (https://data.glygen.org).
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INTRODUCTION

Glycosylation is one of the most abundant, complex and diverse post-translational
phenomena. The process by which aglycones mainly proteins or lipids are modified by
glycans to form glycojugate is ubiquitous and essential to all life forms. Significant
research has taken place to study the synthesis, structure, function, and metabolism of
glycans for its application in numerous diverse fields (O'Neill et al. 2015; Penades et al.
2015; Reily et al. 2019; Seeberger and Cummings 2015).

Role of glycans

The main driver for the glycobiology research has been human health and disease. This
is primarily due involvement of the process in many important biological functions like
transcription, translation, cell division, cellular differentiation, tissue development, cell
adhesion, cell-cell interactions, protein folding and stability, inflammatory responses and
many others (Varki 2017; Varki and Gagneux 2015). Altered glycosylation can be seen
in different diseases like cancer, autoimmune disorders (Rheumatoid arthritis, IBS, etc.),
and others. This has encouraged researchers to identify and study the differential
glycosylation (i.e. alterations to the sialyation, fucosylation, branching, structure, etc.) for
development of diagnostic and prognostic biomarkers. Examples include analyzing core
fucosylation and protein concentration of alpha fetoprotein L3 as biomarker for
hepatocellular carcinoma (Kirwan et al. 2015; Shiraki et al. 1995) or profiling altered
glycoforms on MUC16 and MUC1 for ovarian cancer (Chen et al. 2013). Glycans and
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glycoproteins are also involved in host-pathogen interaction and have many important
roles including entry, mediation and proliferation of pathogens into host cells, glycan
shielding by pathogens against host’s immune response, utilization of glycoproteins by
host as barriers against pathogens as well as triggering an immune response in host
upon pathogen recognition. (Crispin et al. 2018; Li et al. 2017; Lin et al. 2020; Miller et
al. 2008; Walls et al. 2016; Wang et al. 2004). It has been understood that the viral
proteins are extensively glycosylated such as spike glycoprotein for SARS-CoV2
(Watanabe et al. 2020), envelop glycoprotein gp120 in HIV-1 (Panico et al. 2016), which
play a vital role in replication and pathogenesis. e.g. mutations in glycosylation’s sites of
the NS1 protein impacts the pathogenicity of Dengue 2 virus (DENV-2) (Crabtree et al.
2005). As a result, the involvement of glycosylation is extensively studied to potentially
develop vaccine targets and therapies e.g. utilization of Heparin sulfate to inhibit HSV-1
entry and infection (Copeland et al. 2008; Sharthiya et al. 2017).

Applications of glycans is not limited to the biomedical field. For several years glycans
have been used in construction and paper making industry, food and beverages,
transportation, and textile industry and extensive research is implemented to
understand the utility in several fields such as renewable energy production, developing
nanomaterials, enhanced polymers as well as generating high-value chemicals
(National Research Council 2021; O'Neill et al. 2015). Due to the global climate crisis
researchers are interested in finding sustainable and economic alternatives to
petroleum-based energy production. One such source is utilizing plant cell walls
consisting of diverse complex polysaccharides such as hemicellulose, cellulose and
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pectin as lignocellulosic biomass for energy production. As a result, several crops are
investigated for production of bioenergy which include switchgrass (Lemus et al. 2014;
Schmer et al. 2008), sudangrass (Acevedo et al. 2019), eucalyptus (Bonifacino et al.
2021), miscanthus (da Costa et al. 2017), poplar and willow (Clifton-Brown et al. 2019).
Additionally, the byproducts developed during the processing of biomass such as xylose
or glucose are also being studied for their role in producing functional chemical
precursors including ethanol, xylitol, hydroxymethlyfurfural, lactic acid (O'Neill et al.
2015). Another application includes utilizing plant glycans to develop polymers with
enhanced properties (Hansen and Plackett 2008; Hartman et al. 2006). Examples
include modifying cellulose to generate cellophane, rayon and other derivatives like
cellulose butyrate, cellulose acetate (National Research Council 2012 ; O'Neill et al.
2015). Due to high tensile strength and stiffness provided by the structure of cellulose, it
is considered for development of lignocellulose based nanomaterials (referred as CNs)
for a wide variety of industry applications including drug delivery systems,
cardiovascular implants, different films (such as barrier, transparent and antimicrobial),
nanofillers, binders, etc. (Daus and Heinze 2010; Figueiredo et al. 2017; Sai Prasanna
and Mitra 2020; Wijaya et al. 2021).

Significance of glycoinformatics

Due to the immense diversity of structures generated through process as well as the
microheterogeneity it is difficult to link structures with essential functions (Cummings
and Pierce 2014; Varki and Gagneux 2015). Thus, it is evident that in-depth knowledge
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of the structure, function of the glycans as well as the associated conjugates, enzymes
and pathways is vital for utilization of glycans and glycoproteins in development of
biomarkers, vaccine design, and therapeutics as well as in renewable energy
production, biofuels, and nanomaterials at a global and commercial level. The influx of
knowledge available through literature needs to be supplemented with biocuration,
standardization and translation of raw data as value-added knowledge into open-access
bioinformatics databases to facilitate further research. However, a problem facing the
bioinformatics community is the availability of published fully-determined glycan
structures (where there is complete information of the arrangement of the
monosaccharides, linkages/anomeric configuration and glycosidic bonds). Even though
it is expected that the glycan analysis provides topology information, it is difficult to
transfer such data from literature to bioinformatics databases without a curator’s effort to
evaluate composition and other supplementary information to generate fully determined
structures. Thus, the knowledge transfer from literature to bioinformatics resources is
lengthened significantly. Among the available glycan and glycoconjugate database
resources available, the resources focused in the paper are briefly described below.
GlyTouCan
GlyTouCan (Tiemeyer et al. 2017) (https://glytoucan.org/) designed to serve a function
analogous to what GenBank serves for nucleotide sequences provides a repository of
uncurated glycans which are fully-defined or with structural ambiguity at multiple levels
which can be described by the Glycan naming and subsumption ontology or GNOme
((http://obofoundry.org/ontology/gno, http://gnome.glyomics.org) (Supplementary Figure
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S1). Depositions made in GlyTouCan may also include monosaccharide compositions
without any structural context or structural representations without complete description
of the linkages between their monosaccharide building blocks. In addition to hosting
over 120,000 glycans (https://glytoucan.org/Structures) and assigning accessions for
individual glycans (which are adopted as primary identifiers by glycoprotein-centric
databases such as GlyGen (York et al. 2020), GlyConnect (Alocci et al. 2019) and
UniCarbKB (Campbell et al. 2014)), GlyTouCan also provides cross-references to
contributing databases and includes other annotations such as digital sequences (such
as GlycoCT (Herget et al. 2008), WURCS (Matsubara et al. 2017)), literature evidence,
and Symbol Nomenclature for Glycans (SNFG) images (Neelamegham et al. 2019;
Varki et al. 2015). GlyTouCan provides text or graphic tools, APIs to search or register
the glycans as well as SPARQL endpoint (http://code.glytoucan.org/rdf-ontology/sparqlqueries/) to download data from the database.
ChEBI
ChEBI (Degtyarenko et al. 2008) (https://www.ebi.ac.uk/chebi/) is a chemical database
of small molecules hosting over 50,000 annotated entries
(https://www.ebi.ac.uk/chebi/statisticsForward.do). ChEBI provides unique identifiers for
chemical entities (including glycans), host text-string representation (such as SMILES,
InChI, InChI key, etc.), 2-D structure of entities, and associated literature evidence. In
addition to providing unique IDs for chemical entities, ChEBI links them to other
important databases including reaction databases like Rhea (Lombardot et al. 2019)
and pathway databases like Reactome (Jassal et al. 2020) that show the individual
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entities that take part in any given reaction (i.e. the reactants and products).
Furthermore, ChEBI also provides ontology
(http://www.obofoundry.org/ontology/chebi.html) for chemical entities where groups,
classes, child-parent relationships are provided and used by a number of research
groups including Gene Ontology (Ashburner et al. 2000; Gene Ontology Consortium
2021) and model species groups. ChEBI provides simple and advances tools to
search, view and download individual entries in SDF formats and provides FTP, Oracle
and SQL dumps for bulk data download
(https://www.ebi.ac.uk/chebi/downloadsForward.do).
PubChem
PubChem (Kim et al. 2021)(https://pubchem.ncbi.nlm.nih.gov/) is an open chemical
database of (primarily) small and large molecules, hosting over 109,000,000
compounds (https://pubchemdocs.ncbi.nlm.nih.gov/statistics) sourced from over 700
resources (https://pubchem.ncbi.nlm.nih.gov/sources). The sourced entities are referred
as “substances” and are associated with unique Substance (SIDs) which are then
standardized to unique “compound” identifiers (or CIDs). PubChem provides 2-D, 3-D
structures, SNFG (SVG) images for glycans, text-string representation (such as IUPACCondensed, LINUCS, WURCS, SMILES, InCHI, etc), chemical and physical properties,
related/similar compounds, biologic descriptions, synonyms, literature evidence and
links to contributing resource(s) for the hosted compounds. Additionally, PubChem
provides upload mechanisms where different groups or organizations can submit and
update data systematically. Moreover, PubChem provides download options for
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individual or bulk download via FTP and other programmatic access services
(https://pubchemdocs.ncbi.nlm.nih.gov/downloads).
GlyGen
GlyGen (https://www.glygen.org/) is a glycoinformatics resource with extensive
glycoprotein and glycan data integrated from various databases. GlyGen data is
primarily divided into protein/glycoprotein and glycan domains where dedicated entry
pages are provided (e.g. https://www.glygen.org/protein/P14210-1 and
https://www.glygen.org/glycan/G17689DH) for each protein and glycan. To facilitate
interoperability, GlyGen uses accessions from UniProtKB (The UniProt Consortium
2021) and GlyTouCan as primary accessions to identify proteins and glycans
respectively. Additionally, several cross-references to other protein databases (like
RefSeq, PDB, etc), glycoprotein databases (like GlyConnect, UniCarbKB, etc.) and
other glycan or chemical databases (such as PubChem, MatrixDB (Clerc et al. 2019),
Glycosciences.DB (Bohm et al. 2019), KEGG glycans (Hashimoto et al. 2006), etc.) are
provided. Additionally, for glycans unique digital representation (GlycoCT, WURCS,
SMILES, IUPAC, GLYCAM IUPAC, etc.), harmonized symbolic nomenclature
representations SNFG, and important annotations such as glycan classification (Nlinked, O-linked, high mannose, core 1, etc.), glycan motifs, glycosylation annotations
(site-specific or global) on proteins (e.g. https://glygen.org/protein/P142101#Glycosylation), relevant supporting publications, as well as protein annotations
related to disease, expression, mutation, etc. are provided. GlyGen also utilizes Gene
ontology, Protein ontology (https://proconsortium.org/) and GNOme. GlyGen provides
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simple, advanced tool to search and perform complex queries across multiple domains.
GlyGen data can be downloaded through GlyGen DATA (https://data.glygen.org/) or via
API (https://api.glygen.org/) or SPARQL (https://sparql.glygen.org/) services.
Additionally, GlyGen also provides comprehensive documentation of integration process
of individual datasets at GlyGen DATA portal via BioCompute objects (Patel et al. 2021;
Simonyan et al. 2017). For example https://data.glygen.org/GLY_000001/v-1.8.25/bco.
It is important to enhance the connectivity across GlyTouCan, ChEBI and PubChem
databases by promoting interoperability of glycan data available at GlyGen, provided by
its project partners. This will allow GlyGen to connect glycans to glycoproteins, reaction
and pathway annotations and ontologies provided by GNOme and ChEBI. This will
allow users to navigate across multiple resources and via one portal. Previously,
UniCarbKB demonstrated the importance of connecting glyco-centric databases with
PubChem with submission of ~1,700 GlycoSuiteDB entries.

RESULTS

The primary goal of this collaboration is to connect GlyGen, PubChem, ChEBI and
GlyTouCan databases at a glycan level and connect them further to reaction and
pathways information or resources. The resulting interoperability will allow users to
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navigate the same glycan across different resources and access information unique to
each database through one domain i.e. GlyGen.

Expanding glycan data coverage in ChEBI

Utilizing the data-flow and collaboration between the databases, over 10,400 glycans
were registered or mapped semi-automatically including 10,121 fully-determined and 25
high-value (i.e. reported on large number of glycoproteins, see Supplementary Table SI)
ambiguously defined glycans. The integrated glycans are annotated with structure data
(for glycans with a PubChem CID cross-reference), formula, charge, mass values,
InChI, InChIKey and SMILES. Additionally, new ChEBI names (while retaining the
original name as a synonym), more precise ontology terms (such as “amino
tetrasaccharide” or acetamides”) are added to generate 3-star curated status entries.
The corresponding GlyGen and GlyTouCan cross-references are added under “Manual
X-ref” whereas PubChem IDs are listed under “Automatic X-ref” sections of the
individual ChEBI entry pages respectively (e.g.
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=70967). Among the integrated glycans
in ChEBI, ambiguously defined glycans (not previously present in ChEBI) are annotated
with ontology, synonyms (in this case WURCS digital sequence) and cross-references
to GlyTouCan and GlyGen databases. However, they defer from other entries such that
1) they are without 2-D structure images due to high number of possible linkages and 2)
the ChEBI names are generated using a specific format which includes prefix of the
source database followed by accession provided by the database (e.g. GlyTouCan
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G06110VR) e.g. https://www.ebi.ac.uk/chebi/searchId.do?chebiId=156559. List of
ambigously defined glycans registered in ChEBI and their corresponding ChEBI IDs can
be found in Supplementary Table SI. Additionally, new ontology classes adapting
Glycan Naming ontology (or GNOme) were created within ChEBI ontology to classify
the amigously defined glycans. Classes such as base-composition
(https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:167481), composition
(https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:167502) and topology
(https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:167503) were created and
linked to the corresponding instances in GNOme.

Moreover, as ChEBI routinely submits entries to the PubChem database, any new
glycans (expect ambiguously defined glycans) added in ChEBI through this
collaboration were also added to the PubChem database. This added either new
glycans to PubChem or added a ChEBI cross-reference to glycans already present in
PubChem. Additionally, it was observed during the integration process that certain
structures (e.g. beta-D-Glucosamine; CID441477) in PubChem were mapped to both its
monomeric (e.g. CHEBI:28393 beta-D-Glucosamine) and polymeric (e.g. Chitosan;
CHEBI:16261) versions in ChEBI. This was because ChEBI represents polymeric
structures where the repeating part of the monomeric structure was represented in
square brackets with an "n" multiplier outside of the brackets was ignored during
PubChem’s processing. Such mappings were corrected by GlyGen by matching the
InChI strings of the entries. The resolved mappings are currently available through
GlyGen (e.g. https://glygen.org/glycan/G19577LJ).
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This collaboration significantly increased the number of glycans (from ~800 in Feb 2020
to ~10,400) in ChEBI as well as increased the number of PubChem CIDs with CHEBI
cross-reference (from ~3729 in April 2020 to ~9409). The integrated glycans can be
accessed via GlyGen DATA portal (https://data.glygen.org/GLY_000296) or individual
pages (e.g. https://glygen.org/glycan/G78059CC#Cross-References) or ChEBI FTP
(ftp://ftp.ebi.ac.uk/pub/databases/chebi/Flat_file_tab_delimited/database_accession.tsv
or CHEBI entry pages (https://www.ebi.ac.uk/chebi/searchId.do?chebiId=70967) or
PubChem FTP (https://ftp.ncbi.nlm.nih.gov/pubchem/Compound/Extras/CID-Synonymfiltered.gz) or individual entry pages (e.g.
https://pubchem.ncbi.nlm.nih.gov/compound/70679232)

Submitting glycan annotations to PubChem

PubChem contains several glycans sourced from different databases such as
GlyTouCan, ChEBI, etc. Utilizing the mapping between GlyTouCan and PubChem
databases, GlyGen submitted important glycan annotations such as glycan motif (e.g.
Lewis X, Type 2 LN), composition (Hex5 HexNAc4 dHex1), per-methylated mass (e.g.
2221.13523366), classification (e.g. N-glycan (complex)) for glycans common between
GlyGen and PubChem Compound databases (e.g.
https://pubchem.ncbi.nlm.nih.gov/compound/25098607#section=Biologic-Description)
Additionally, the individual monosaccharides in the composition section are further
linked to the corresponding PubChem Compound pages (e.g. Hex or Hexose is linked
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to https://pubchem.ncbi.nlm.nih.gov/compound/206). Glycosylation annotations from
GlyGen are also submitted to the “Glycobiology” section of the PubChem protein pages.
Annotations such as the glycosylation site, glycosylation type (e.g. N-linked),
GlyTouCan accession, glycan images (SNFG format), literature evidence in form a table
is provided for associated protein entries. Additionally, a glycosylation summary stating
the total number of glycosylation sites and the total number of N-liked and O-linked sites
is provided at the top. E.g.
https://pubchem.ncbi.nlm.nih.gov/protein/P00533#section=Glycosylation. The table displays

only those glycosylation sites where the corresponding glycan is also present in the
PubChem Compound database (i.e. has CID). This connectivity promotes
interoperability within PubChem Protein and Compound pages. All annotations
submitted by GlyGen can be found on PubChem’s data sources page
(https://pubchem.ncbi.nlm.nih.gov/source/23201) or can be found at GlyGen DATA
(glycan list: https://data.glygen.org/GLY_000281, glycan classification:
https://data.glygen.org/GLY_000282, glycan motif: https://data.glygen.org/GLY_000283,
glycan monosaccharide composition: https://data.glygen.org/GLY_000286,
glycosylation annotations: https://data.glygen.org/GLY_000499).

This process enriches the existing glycan and protein data available in PubChem and
connects them together through glycosylation information within the same database.
Annotations submitted by GlyGen are systematically added and regularly updated to
ensure synchronization between the two databases. Additionally, all the submitted
annotations are bi-directionally linked at a glycan and protein level with GlyGen.
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Connecting glycans to reaction and pathway resources

Major glycoprotein databases (such as UniCarbKB, GlyConnect) use GlyTouCan
accessions as primary identifiers to report glycans, whereas, reaction or pathway
databases (like Rhea or Reactome) uses ChEBI Ids (See Figure 1). GlyGen utilized the
GlyTouCan accession to ChEBI ID mapping to connect glycans with glycosylation
annotations as well as enzymes and pathways information under one domain. E.g. in
GlyGen glycan G96881BQ is connected to glycosylation information at section:
https://glygen.org/glycan/G96881BQ#Associated-Protein (where information about the

protein, site, source (database, literature evidence) is provided) and to reaction and
pathway information through cross-references with Rhea (https://www.rheadb.org/rhea/25580) and Reactome (https://reactome.org/content/detail/R-ALL-6787679) at

section:
https://glygen.org/glycan/G96881BQ#Cross-References. The Rhea cross-reference provides

information on reaction, participants and literature evidence, whereas, the Reactome
cross-reference provides pathways and reaction information for the compound in
different species.
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DISCUSSION

Just as the usefulness of genomic and proteomic resources grew as their coverage of
genes and proteins expanded, so too will the usefulness of glycan and glycosylation
databases increase as the number of well-mapped glycan structures approaches
comprehensive coverage. For glycans, reaching this goal has added difficulty due to
the chemical nature of the compounds and the inherent limitations of the approaches for
their structural analysis. Therefore, well developed submission pipelines that capture
and cross-link as much information as possible are essential for growth in the
glycosciences and for connecting glycan data to broader bioinformatics domains.

Novelty

GlyTouCan, PubChem and ChEBI are major bioinformatics resources that are routinely
used by many different research groups. However, the ChEBI and PubChem databases
have significantly less glycan data compared to GlyTouCan. This novel pipeline allows
integration of valuable glycan and glycan-related annotations hosted by GlyGen into
PubChem and ChEBI databases while maintaining the links to GlyTouCan database.
Additionally, ChEBI’s routine submissions to PubChem allows the newly integrated
glycans to be further integrated into the PubChem database. As a result, this pipeline is
not only able to identify and increase the glycan data coverage in ChEBI and PubChem
databases but is also able to synchronize and map these entries ensuring connectivity.
Moreover, the established connection allows further mapping and integration of other
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important resources (such as Rhea or Reactome) to connect reaction and pathway
annotations which were previously isolated from glycoprotein data. Through this
collaboration, interoperability of glycan data is achieved systematically between major
databases while providing access to valuable annotations and features unique to each
database.

Applications

Currently, the glycosylation data available in the UniProt database describes the
protein, glycosylation site, associated literature (for reported glycosylation) and in some
cases additional description (such as high mannose, etc.) about the glycan or
glycosylation (e.g. https://www.uniprot.org/uniprot/P00533#ptm_processing). However it
lacks the information on the specific glycan that may be reported on a particular site on
the protein. Through GlyGen’s collaboration, specific glycans (sourced from multiple
resources) will be annotated to the protein and site data already present in the UniProt
database (see Supplementary Figure S2). These glycans originally identified by
GlyTouCan accessions by source databases and later mapped to ChEBI ID’s by
GlyGen will be added to the glycoprotein sites at the ProtVista browser in UniProt.
ProtVista is a protein browser providing a compact representation and access to the
functional amino acid residue annotation in UniProt such as domains, sites, posttranslational modifications and variants. Protvista is available through the UniProt web
site and the source code is publicly available through as a web component
(https://github.com/ebi-webcomponents/protvista-uniprot). The submitted glycans
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(identified by a ChEBI ID) along with a 2-D image will be cross-referenced to GlyGen
protein pages. Additionally, UniProt users will be able to query for glycans connecting
them to knowledge on proteins e.g. proteins that bind them and enzymes that
synthesize or degrade them.

Future plans

In order to sustain the growing GlyGen glycan collection, one of the major goals is to
automate ~90% of the submission pipeline and reduce the time required to manually
register ambiguously defined glycans. We also plan to document this pipeline so that
resources like GlyTouCan, GlyConnect, and others can utilize this pipeline to integrate
their glycans into the ChEBI and the PubChem databases directly or via GlyGen.
Additional plans include the generation of tutorials so that users can directly register or
map ambiguously-defined glycans into the ChEBI database. This can be achieved by
using the PubMed ID or other publication or database identifier as a ChEBI name for the
glycan entries in order to comply with the ChEBI registration protocols. Additionally, as
GNOme also provides glycan-glycan relationships (using GlyTouCan accession as the
primary identifier), the ambiguously defined glycans can be potentially linked to possible
fully-determined, structurally-related glycans within the ChEBI database.
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MATERIALS AND METHODS

The GlyTouCan database hosts over 120,000 glycans, each identified by a GlyTouCan
accession. The glycans hosted by GlyTouCan are generally deposited by various
groups or individual researchers and often include glycans that are not curated and/or
lack important annotations such as species, expression system, etc. As a result,
GlyGen has developed an inclusion criteria in an effort to generate a subset of glycans
that are unique and biologically relevant. These glycans along with valuable annotations
(sourced via GlyGen’s collaborators) are available under GlyGen’s domain.

Rules to generate GlyGen glycan set

The GlyGen glycan set (v1.5.13) comprises a subset (~24%) of the total GlyTouCan
glycan set and is seeded with GlyTouCan glycan accessions annotated as human
(NCBI Tax ID: 9606), mouse (NCBI Tax ID: 10090), rat (NCBI Tax ID: 10116), HCV1a
(NCIB TaxID: 63746), SARS CoV 2 (NCBI TaxID:2697049) by GlyTouCan, UniCarbKB,
or GlyConnect glycan data-resources; glycans representing motifs from the GlycoMotif
(http://glycomotif.glyomics.org) glycan motif data-resource; GlyGen synthetic glycans;
and glycans observed in human contexts in the GPTwiki (http://gptwiki.glyomics.org)
glycopeptide transition data-resource. The GlyGen glycan set is then extended to
include any GlyTouCan glycan accession that subsumes or shares a monosaccharide
composition with a seed-glycan using the GNOme glycan naming and subsumption
ontology (http://obofoundry.org/ontology/gno, http://gnome.glyomics.org). (See
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Supplementary Figure S3). GlyGen data processing and integration framework is
utilized to quality control and standardized this data which is supplied to GlyGen portal
(Kahsay et al. 2020).

Harmonization of glycans between different databases

GlyTouCan and ChEBI databases routinely submit entities (as MDL SDF files) to
PubChem which are classified as “substances” and identified by unique substance or
SIDs. The standardization process then validates and normalizes the chemical entities
to generate a PubChem compound database where the standardized compound is
identified by a unique CID (Kim et al. 2016). Multiple SIDs can map to the same CID
(see Figure 2).

PubChem only accepts glycans where the arrangement of the monosaccharides,
glycosidic bonds and linkages or anomeric positions are known. However, ambiguity
regarding the first linkage (between the glycan and conjugate) and stereochemistry of
any particular atom is tolerated within PubChem. As a result, not all GlyTouCan
accessions are included in the PubChem database. Additionally, before the start of the
collaboration only a small portion of the available glycans in PubChem were mapped to
the ChEBI database resulting in low connectivity across GlyTouCan, PubChem and
ChEBI databases.
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As an attempt to harmonize glycans between GlyTouCan and ChEBI, the GlyGen
glycan set (v.1.5.13) comprising 29,290 glycans was identified as the primary list. The
set contains 19,039 glycans associated with saccharide subsumption category as
defined by the Glycan Naming Ontology or GNOme (for description of GNOme classes
see Supplementary Figure S1). Rest includes glycans associated with topology (6143),
composition (2652), base composition (1386) and undefined (97) categories. The set
also includes 13,389 fully-determined glycans that belong to either saccharide, topology
or composition subsumption categories. An integration pipeline was developed to map
and register all GlyGen glycans into the ChEBI database (see Figure 3).

Using PubChem as an anchor database.

PubChem Compound was used as an anchor database to identify the existing mapping
between the GlyTouCan and ChEBI databases. Out of the GlyGen glycan list of 29,290
GlyTouCan accessions 10,496 were already cross-referenced to PubChem compound
identifiers (CIDs). These mostly included glycans which are fully-determined with or
without known first linkage (between the glycan and conjugate). This set also includes
glycans which consists of a single monosaccharide as well glycans with one or more
undefined atomic stereocenter. This mapping was utilized to retrieve the corresponding
PubChem CID to ChEBI ID mapping (e.g. using the mapping between GlyTouCan
G14047PA to PubChem CID 70788991 and ChEBI:72002 to PubChem CID 70788991,
the GlyTouCan accession was mapped to the ChEBI ID). As a result, over 1,700
glycans were mapped between the GlyTouCan and ChEBI databases. However, this
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method provided only about 5% coverage for the GlyGen glycan set. As for the
remaining PubChem CIDs where a ChEBI ID mapping was not directly available from
the PubChem database, the integration pipeline was modified so that the structure data
for individual entries (downloaded from PubChem) could be uploaded into applications
like KNIME (Fillbrunn et al. 2017) and ClassyFire (Djoumbou Feunang et al. 2016) to
generate a suitable SD file for ChEBI. In this process, the downloaded PubChem
structure data for individual entries were uploaded to the KNIME application where the
data was first cleaned (e.g. remove explicit hydrogens while maintaining the
stereochemical integrity of the structure) and the additional information (such as
associated names, synonyms and WURCS sequence) was extracted. The data was
further uploaded to the ClassyFire application (at 12 requests per minute rate) in order
to generate ontology terms. The generated ontology terms were then converted to the
best matching ChEBI ontology terms and an SD file for ChEBI upload was generated. A
default classification value (such as carbohydrates and carbohydrates-derivatives) was
added in cases where ClassyFire was unable to generate an ontology term for a record.
The files generated by the KNIME application were submitted to the ChEBI loader tool
(in batches of 250 records) and the GlyTouCan accession (via PubChem CID) was
either mapped to an existing ChEBI ID (if the structure was already present in ChEBI) or
registered as a new entry with 2-star status. This method allowed integration of any
GlyTouCan accession (within GlyGen) with a PubChem CID into the ChEBI database.

Manual registration of glycans into ChEBI
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The PubChem Compound database facilitated mapping or registration of roughly 30%
of the GlyGen glycans (GlyTouCan accessions) into the ChEBI database. The
remaining set of 18,794 glycans lacked a PubChem CID, likely as they did not fit the
PubChem requirements. This includes (but not restricted to) glycans that strictly
compositions (e.g. G00058XR or G00057LF) or glycans with undefined stereochemistry
(e.g G00318AV or G00012RZ). However, this set also includes about 3256 fullydetermined glycans which lack a PubChem CID probably due to a technical error or a
database synchronization issue between PubChem and the GlyTouCan database.

To establish and optimize a protocol, twenty-five high-value glycans (GlyTouCan
accession) were selected to be manually registered into ChEBI (see Supplementary
Table SI) as a proof of concept. The subset was identified based on the following
conditions: 1) Top-ten composition glycans with the largest number of associated
proteins in GlyGen (v1.5.36). 2) Top-ten ambiguously-defined glycans with the largest
number of associated proteins in GlyGen (v1.5.36) and 3) Five composition glycans
associated to the HCV1a protein in GlyGen (v1.5.36). Based on the following
approaches the remaining glycans will be registered manually: 1) Fully determined
glycans: Such glycans can be treated as ordinary chemical entities in the same manner
as most of the other entities in the ChEBI database. Entries can be added by a ChEBI
curator using the Curator tool, or by individual submitters using the ChEBI submissions
tool (in which a submitter provides a name, structure, etc.). Each submission is
immediately visible on the public website as a 2-star (unchecked) entry and is upgraded
to 3-star (checked) status after being checked by a ChEBI curator. After being indexed
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overnight, submissions can be fully searched, for example, by name, synonyms, InChI,
InChIKey, SMILES, and structure, the following day. 2) Glycans with unknown
stereochemistry: In principle, all of the methods described for fully determined
structures can be used in cases where some (or all!) of the stereochemistry is unknown.
If the alpha/beta configuration of one or more glycosidic bonds in a glycan is not known,
then such bonds are depicted in the chemical structure as normal single bonds. For
double bonds of unknown configuration, ‘wavy’ bonds can be used to link the double
bond to one or more of its substituents. 3) Glycans with unknown position of
attachment: If the position of attachment of a glycosyl group to a glycan is not known,
then the structure is drawn using “R” atoms to indicate the possible sites of attachment.
In the Definition field, a note is included to indicate the possible values of R at each
position 4) Compositions: In cases where only the composition such as the type
(hexose, pentose, etc.) and number of monosaccharides is known then such glycans
can be registered using the source (in this case GlyTouCan) accession as a ChEBI
name and the composition of a glycan (e.g. Composition: Hex2 HexNAc5.) can be
added as part of the description. However, due to high number of possible linkages,
such entries would lack a ChEBI image.

Integration of glycan annotations to PubChem

A sustainable approach was developed to submit glycan and glycoprotein annotations
from GlyGen to PubChem Compound and protein pages. After registering GlyGen as a
user through PubChem upload mechanism (https://pubchem.ncbi.nlm.nih.gov/upload/)
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stable unique URLs of annotation specific GlyGen datasets (e.g.
https://data.glygen.org/GLY_000283) are regularly and automatically consumed by the
PubChem database to add and update the annotations. Each compound in PubChem
has a dedicated page and is identified with a unique compound identifier (or CID) which
represents a standardized entry from multiple substances submitted to PubChem.
Utilizing the existing GlyTouCan accession to PubChem CID mapping and GlyGen’s
annotation specific dataset, annotations such as GlyGen glycan list
(https://data.glygen.org/GLY_000281), glycan classification
(https://data.glygen.org/GLY_000282), glycan motif (https://data.glygen.org/GLY_000283),
and monosaccharide composition (https://data.glygen.org/GLY_000286) were added to
the respective PubChem Compound page. The annotations were added under the
‘Biologic Description’ section on the PubChem Compound page along with the URL for
the GlyGen glycan page. The individual monosaccharides within the glycan composition
are further linked to respective entries within PubChem Compound pages. Similar to the
Compound pages, PubChem has dedicated pages for the proteins identified by the
NCBI Protein accessions. Utilizing the UniProtKB accession, GlyGen provided the
respective glycoprotein annotations (using dataset https://data.glygen.org/GLY_000499)
to the PubChem Protein pages. The annotations are added under the ‘Glycobiology’
section along with a link to GlyGen Protein pages. The section also contains a table that
shows glycosylation information including glycosylation site, glycosylation type,
GlyTouCan ID, glycan image, PubChem CID, and PMID evidence for only a subset of
glycoprotein annotations where the associated glycan (GlyTouCan accession) has a
corresponding PubChem CID for a given glycoprotein.
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LEGENDS TO FIGURES

Figure 1: Network of the glycan annotations sourced from various databases which use
either ChEBI ID or GlyTouCan accessions as primary identifiers. Utilizing the ChEBI ID
to GlyTouCan accession mapping, GlyGen is able to map across multiple databases
connecting glycan with information on glycosylation, reaction, and pathway (e.g.
https://glygen.org/glycan/G96881BQ#Cross-References). This network is restricted to

human proteins.

Figure 2: Outlines the data flow of glycans across GlyTouCan, ChEBI, and PubChem
databases. The figure shows an example of the same glycan ( beta-D-Galp-(1->3)[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc) present in GlyTouCan (G00033MO) and
ChEBI (62158) under respective database identifiers. The GlyTouCan accession and
ChEBI ID is mapped to unique PubChem Substance identifiers (G00033MO to
SID:252289141; CHEBI:62158 to SID:123058952) when submitted to the PubChem
database. PubChem’s standardization process maps both the SID’s to a single
compound identifier (CID:52921656). The same CID is utilized as a cross-reference by
both GlyTouCan and ChEBI databases.

Figure 3: Overview of the data integration pipeline to map or register the GlyGen glycan
set of 29,290 GlyTouCan accessions into the ChEBI database. If the GlyTouCan
accession had a PubChem CID and a corresponding ChEBI ID, then a cross-reference
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mapping was generated and added to the ChEBI database where the corresponding
GlyTouCan accession was added as a cross-reference. GlyTouCan accessions with a
PubChem CID but without a ChEBI ID were uploaded to ChEBI using applications like
KNIME and ClassyFire. The remaining GlyTouCan accessions where a PubChem CID
mapping was missing were manually registered in the ChEBI database.

